查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606473

基於人工智慧的疾病診斷市場，按組件類型、診斷類型和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

AI-based Disease Diagnosis Market, By Component Type, By Diagnosis Type, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

基於人工智慧的疾病診斷市場預計到 2023 年將達到 13.545 億美元，2024 年至 2032 年複合年成長率為 24.20%。

此外，疾病檢測中的人工智慧可以支援個人化治療，這在世界醫療保健系統中迅速普及。預計在預測期內，對傳統醫療基礎設施不斷成長的需求將為基於人工智慧的疾病診斷市場帶來顯著的成長動力。然而，創建和實施該技術的高成本可能會影響市場成長率。

基於人工智慧的疾病診斷市場-市場動態

全球患者數量不斷增加，醫療基礎設施不斷惡化

全球患者數量的不斷成長預計將推動基於人工智慧的疾病診斷市場的成長。需要醫療照護的人數不斷增加，給目前的醫療保健系統帶來了巨大壓力。由於缺乏診斷中心、醫療保健從業人員和設施以及醫療保健成本不斷上漲，許多人無法獲得高品質的醫療。據市場調查顯示，非洲每萬人就有一名醫生。已開發國家以及世界其他地區也有類似的數字。此外，2019 年世界經濟論壇的一項研究稱，富裕國家醫療保健品質不佳，每年導致超過 600 萬人死亡。此外，患者數逐年增加。患者數量的增加歸因於抗藥性菌株的出現、人口老化以及自體免疫疾病患者數量的增加。透過利用人工智慧進行疾病診斷，現有的醫療保健系統可以更好地滿足患者不斷變化的要求和需求。

基於人工智慧的疾病診斷市場-關鍵見解

根據我們的研究分析師的分析，預計在 2024 年至 2032 年的預測期內，全球市場將以約 24.20% 的複合年成長率擴張。

根據組件類型，預計軟體類別將在 2023 年佔據最大的市場佔有率。

根據診斷類型，預計放射學類別將在 2023 年佔據最大的市場佔有率。

2023 年，按地區分類，北美地區的收入佔有率最大。

基於人工智慧的疾病診斷市場-細分分析：

全球基於人工智慧的疾病診斷市場分為組件類型、診斷類型和區域。

根據組件類型，市場分為三個部分：軟體、服務和硬體。 2023 年，軟體領域帶來的收入最多。人工智慧診斷的主要組成部分是整合到軟體平台中的複雜演算法和機器學習模型。軟體是人工智慧驅動診斷的基礎，因為這些平台可以評估複雜的醫療資料（包括成像和基因組資料），並提供有用的見解。醫療保健從業者可以透過不斷更新和改進具有新功能、演算法和功能的軟體來維持診斷技術的前沿。人工智慧診斷的快速發展使得這種靈活性和可擴展性變得至關重要。

就診斷類型而言，市場分為心臟病學、腫瘤學、放射學、胸肺學、神經學、病理學等。 2023 年，就收入佔有率而言，市場領導者是放射科。放射學研究需要分析大量來自 CT、MRI、超音波和 X 光的醫學圖片。由於人工智慧工具非常擅長處理和解讀這些影像，因此放射學是整合人工智慧的好地方。人工智慧快速且精準的影像分析大大提高了診斷效率並引發了廣泛應用。最早使用人工智慧的醫學專業之一是放射學，即影像解釋和識別。自從人工智慧首次應用於放射學以來，更複雜、更先進的人工智慧技術已經被開發出來。它們現在在醫療機構中廣泛使用和信任，這有助於該行業的蓬勃發展。

基於AI的疾病診斷市場-地理洞察

基於人工智慧的疾病診斷市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲。這些區域根據提供業務的國家進一步分類。

2023年，北美在基於人工智慧的疾病診斷領域引領全球市場。在使用新技術進行患者治療和疾病診斷方面，美國處於領先地位。此外，開發識別人工智慧技術與臨床護理環境中實際實施之間任何不一致的能力將是工作的重點。患者和醫療專業人員都將從這些改進中受益。

基於人工智慧的疾病診斷市場預計亞太地區將成為第二大收入來源。由於當地醫療機構、投資和人工智慧技術發展的壓力日益加大，該地區的人口數量將會增加。內視鏡頂級製造商之一奧林巴斯於2024年7月表示，將利用AI進軍診斷平台市場。透過使用將平台連接到醫院內視鏡的雲端服務，該試點計畫將在亞太地區推出。

基於人工智慧的疾病診斷市場-競爭格局：

基於AI的疾病診斷市場存在Babylon Health、Tempus、Arterys、IBM Watson Health、Insilico Medicine、Zebra Medical Vision等幾大主要競爭對手，技術創新和策略聯盟是重點。企業正在花錢購買由人工智慧支援的分析平台，這些平台可以提供有關患者結果和疾病趨勢的更深入的知識。為了提供更準確、更快速、更精確的結果，人們也越來越重視將人工智慧與當前基礎設施和醫學影像功能結合。此外，數位公司和醫療保健提供者之間的合作不斷成長，刺激了創新並擴大了人工智慧工具和解決方案在一系列醫療保健領域的使用。

最新進展：

2024 年 6 月：Aidoc 剛剛發布了新的人工智慧患者管理系統，該系統提高了診所的吞吐量並改善了患者護理。預計此次推出將提高公司在市場中的地位並擴大其客戶群。

2024年6月：AliveCor宣布Kardia 12L心電圖系統及其KAI 12L人工智慧技術已獲得FDA批准並將開始銷售。由於此次批准，預計該公司的銷售前景在不久的將來將會改善。

2024 年 4 月：MindSculpt Analytics 和 Happiest Mind Technologies Limited 宣布合作。新的合作夥伴關係重點關注個人健康和保健，旨在利用人工智慧和機器學習技術提供尖端的醫療診斷解決方案。

目錄

第1章：基於人工智慧的疾病診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 基於人工智慧的疾病診斷市場片段（按組件類型）
    • 基於人工智慧的疾病診斷市場片段（按診斷類型）
    • 基於人工智慧的疾病診斷市場片段（按國家/地區）
    • 基於人工智慧的疾病診斷市場片段（按地區）
  • 競爭洞察

第 3 章：基於人工智慧的疾病診斷主要市場趨勢

  • 基於人工智慧的疾病診斷市場促進因素
    • 市場促進因素的影響分析
  • 基於人工智慧的疾病診斷市場限制
    • 市場限制影響分析
  • 基於人工智慧的疾病診斷市場機會
  • 基於人工智慧的疾病診斷市場未來趨勢

第4章：人工智慧疾病診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：基於人工智慧的疾病診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基於人工智慧的疾病診斷市場格局

  • 2023年基於人工智慧的疾病診斷市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：基於人工智慧的疾病診斷市場 - 按組件類型

  • 概述
    • 按組件類型分類的細分市場佔有率分析
    • 軟體
    • 服務
    • 硬體

第 8 章：基於人工智慧的疾病診斷市場 - 按診斷類型

  • 概述
    • 按診斷類型分類的細分市場佔有率分析
    • 心臟病學
    • 腫瘤學
    • 放射科
    • 胸肺
    • 神經病學
    • 病理
    • 其他

第 9 章：基於人工智慧的疾病診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 基於人工智慧的疾病診斷北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按組件類型）
    • 北美市場規模和預測（按診斷類型）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲基於人工智慧的疾病診斷主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按組件類型）
    • 歐洲市場規模和預測（按診斷類型）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區基於人工智慧的疾病診斷主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按組件類型）
    • 亞太地區市場規模和預測（按診斷類型）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲基於人工智慧的疾病診斷主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按組件類型）
    • 拉丁美洲市場規模和預測（按診斷類型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 基於人工智慧的疾病診斷中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按組件類型）
    • 中東和非洲市場規模及預測（按診斷類型）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第10章：主要供應商分析-基於人工智慧的疾病診斷產業

  • 競爭儀表板
  • 公司簡介
    • Babylon Health
    • Tempus
    • Arterys
    • IBM Watson Health
    • Insilico Medicine
    • Zebra Medical Vision
    • PathAI
    • Buoy Health
    • Freenome
    • Lunit
    • Viz.ai
    • Aidoc
    • Butterfly Network
    • CureMetrix
    • Qure.ai.
    • Others

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4269

REPORT HIGHLIGHT

The market for AI-based Disease Diagnosis was projected to reach USD 1,354.5 million in 2023 and expand at a CAGR of 24.20% between 2024 - 2032.

The employment of artificial intelligence (AI) technology in the healthcare sector during the disease diagnosis stage is known as AI-based disease diagnosis. Demand for and investment in AI in healthcare has been rising quickly across all industries. The trend is fueled by a number of benefits that AI technology provides. Recently, artificial intelligence has drawn interest from all across the world. In order to duplicate human intelligence, the technology makes use of a number of cutting-edge technologies. Medical picture analysis, disease prediction, and condition detection are just a few of the advanced jobs that AI allows machines to accomplish.

Additionally, AI in disease detection can support individualized treatment, which is rapidly gaining popularity in the world's healthcare system. The growing demand for conventional healthcare infrastructure is anticipated to generate significant growth momentum for the AI-based disease diagnosis market during the projected period. However, the high cost of creating and implementing the technology may affect the rate of market growth.

AI-based Disease Diagnosis Market- Market Dynamics

Growing Number of Patients Worldwide, as well as the Deteriorating Healthcare Infrastructure

The growing number of patients worldwide is anticipated to fuel growth in the market for AI-based disease diagnostics. The growing number of people in need of medical care is putting a great deal of strain on the current healthcare system. Many people lack access to high-quality medical treatment as a result of the absence of diagnostic centers, healthcare practitioners, and facilities, as well as the rising cost of healthcare. According to a market survey, there is one doctor for every 10,000 people in Africa. Developed countries, as well as other parts of the world, have similar figures. Moreover, a 2019 World Economic Forum research claims that the inadequate quality of healthcare in wealthy countries causes over 6 million deaths annually. In addition, the number of patients has been increasing annually. The rise in the number of patients is ascribed to the development of drug-resistant disease strains, the aging of the population, and the growing number of autoimmune disease patients. The existing healthcare system can better meet the evolving requirements and demands of patients by utilizing artificial intelligence in disease diagnostics.

AI-based Disease Diagnosis Market- Key Insights

According to our research analyst's analysis, the global market is projected to expand at a CAGR of approximately 24.20% during the forecast period of 2024-2032.

The software category was predicted to hold the largest market share in 2023 based on component type.

The radiology category was predicted to hold the largest market share in 2023 based on diagnosis type.

North America held the largest revenue share by region in 2023.

AI-based Disease Diagnosis Market- Segmentation Analysis:

The Global AI-based Disease Diagnosis Market is segmented into Component Type, Diagnosis Type, and Region.

The market is divided into three segments based on the component type: software, services, and hardware. In 2023, the software segment brought in the most money. The main components of AI diagnostics are complex algorithms and machine learning models that are integrated into software platforms. Software is the foundation of AI-driven diagnostics since these platforms evaluate intricate medical data, including imaging and genomic data, and offer useful insights. Healthcare practitioners can stay on the cutting edge of diagnostic technology by continually updating and improving software with new features, algorithms, and capabilities. The quick development of AI diagnostics has made this flexibility and scalability essential.

In terms of diagnosis type, the market is segmented into Cardiology, Oncology, Radiology, Chest & Lung, Neurology, Pathology, and Others. In 2023, the market leader in terms of revenue share was the radiology segment. The study of radiology entails analyzing vast amounts of medical pictures from CT, MRI, ultrasound, and X-rays. Because AI tools are so good at processing and deciphering these images, radiology is a great place to integrate AI. AI's rapid and precise picture analysis has greatly increased diagnostic effectiveness and sparked widespread use. One of the first medical specialties to use AI was radiology, namely in picture interpretation and recognition. Since AI was first used in radiology, more sophisticated and advanced AI technologies have been developed. They are now extensively used and trusted in healthcare institutions, which has helped the industry flourish.

AI-based Disease Diagnosis Market- Geographical Insights

The AI-based Disease Diagnosis market is widely distributed geographically in North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further separated based on the countries that provide business.

North America led the global market for AI-based disease diagnosis in 2023. Due in large part to its highly developed and technologically advanced health infrastructure, the United States is the most powerful country in North America. When it comes to using new technologies for patient treatment and disease diagnosis, the US has led the way. Additionally, developing the ability to identify any misalignment between AI-enabled technologies and practical implementations in the clinical care setting will be the focus of the efforts. Patients as well as medical professionals, will benefit from these improvements.

The AI-based disease diagnosis market is expected to see Asia-Pacific become the second-largest revenue generator. The region will increase as a result of the increasing strain on local healthcare organizations, investments, and developments in AI technology. One of the top manufacturers of endoscopes, Olympus, said in July 2024 that it will use AI to enter the diagnostic platform market. With the use of a cloud-based service that links the platform to hospital endoscopes, the pilot project will be introduced in Asia Pacific.

AI-based Disease Diagnosis Market- Competitive Landscape:

Several major competitors, such as Babylon Health, Tempus, Arterys, IBM Watson Health, Insilico Medicine, and Zebra Medical Vision, among others, are present in the AI-based disease diagnosis market, and technological innovation and strategic alliances are prioritized. Businesses are spending money on analytics platforms powered by AI that offer more in-depth knowledge about patient outcomes and illness trends. In order to provide more accurate, quick, and exact results, there is also an increasing emphasis on integrating AI with current infrastructure and medical imaging capabilities. Additionally, collaborations between digital companies and healthcare providers are growing, spurring innovation and broadening the use of AI tools and solutions in a range of healthcare fields.

Recent Developments:

June 2024: The new AI-powered patient management system from Aidoc, which increases clinic throughput and advances patient care, was just released. It is anticipated that this launch will improve the company's standing in the marketplace and allow it to grow its clientele.

June 2024: AliveCor declared that the Kardia 12L ECG System and its KAI 12L AI technology had received FDA approval and would be going on sale. The company's sales prospects are anticipated to improve in the near future as a result of this approval.

April 2024: MindSculpt Analytics and Happiest Mind Technologies Limited announced their collaboration. With an emphasis on personal health and wellness, the new partnership seeks to provide cutting-edge medical diagnostic solutions by utilizing artificial intelligence and machine learning technology.

SCOPE OF THE REPORT

The scope of this report covers the AI-based Disease Diagnosis market by its major segments, which include as follows:

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Babylon Health
  • Tempus
  • Arterys
  • IBM Watson Health
  • Insilico Medicine
  • Zebra Medical Vision
  • PathAI
  • Buoy Health
  • Freenome
  • Lunit
  • Viz.ai
  • Aidoc
  • Butterfly Network
  • CureMetrix
  • Qure.ai.
  • Others

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY COMPONENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cardiology
  • Oncology
  • Radiology
  • Chest & Lung
  • Neurology
  • Pathology
  • Others

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI-based Disease Diagnosis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI-based Disease Diagnosis Market Snippet by Component Type
    • 2.1.2. AI-based Disease Diagnosis Market Snippet by Diagnosis Type
    • 2.1.3. AI-based Disease Diagnosis Market Snippet by Country
    • 2.1.4. AI-based Disease Diagnosis Market Snippet by Region
  • 2.2. Competitive Insights

3. AI-based Disease Diagnosis Key Market Trends

  • 3.1. AI-based Disease Diagnosis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI-based Disease Diagnosis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI-based Disease Diagnosis Market Opportunities
  • 3.4. AI-based Disease Diagnosis Market Future Trends

4. AI-based Disease Diagnosis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI-based Disease Diagnosis Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI-based Disease Diagnosis Market Landscape

  • 6.1. AI-based Disease Diagnosis Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI-based Disease Diagnosis Market - By Component Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component Type, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services
    • 7.1.4. Hardware

8. AI-based Disease Diagnosis Market - By Diagnosis Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis Type, 2023 & 2032 (%)
    • 8.1.2. Cardiology
    • 8.1.3. Oncology
    • 8.1.4. Radiology
    • 8.1.5. Chest & Lung
    • 8.1.6. Neurology
    • 8.1.7. Pathology
    • 8.1.8. Others

9. AI-based Disease Diagnosis Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. AI-based Disease Diagnosis Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. AI-based Disease Diagnosis Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. AI-based Disease Diagnosis Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. AI-based Disease Diagnosis Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. AI-based Disease Diagnosis Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- AI-based Disease Diagnosis Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Babylon Health
    • 10.2.2. Tempus
    • 10.2.3. Arterys
    • 10.2.4. IBM Watson Health
    • 10.2.5. Insilico Medicine
    • 10.2.6. Zebra Medical Vision
    • 10.2.7. PathAI
    • 10.2.8. Buoy Health
    • 10.2.9. Freenome
    • 10.2.10. Lunit
    • 10.2.11. Viz.ai
    • 10.2.12. Aidoc
    • 10.2.13. Butterfly Network
    • 10.2.14. CureMetrix
    • 10.2.15. Qure.ai.
    • 10.2.16. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us